Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to December 2025, from the company's annual filing with the SEC.
| Salesyearly sales | $5.2B |
| Sales growthchange from the year before | +24.1% |
| Gross marginshare of sales left after the direct cost of what it sells | 40.6% |
| Operating marginshare of sales left after running the business | 30.6% |
| Net marginshare of sales kept as profit | 29.3% |
| Free-cash-flow marginspare cash generated per $100 of sales | 22.7% |
| Return on invested capitalprofit made on each $100 put into the business | 12.8% |
| Return on equityprofit vs. shareholders' accounting value | 16.0% |
| Debt / equitydebt vs. shareholders' accounting value | 0.03 |
| Change in share countnegative = the company is buying back its shares | 0.0% |
2 insiders sold $2.5M (all under pre-arranged plans) on the open market.
| Gloeckler MarkusChief Technology Officer | Sold (plan)Aug 4 | 829 shat $248.00 · $206K |
| Koralewski MichaelChief Supply Chain Officer | Sold (plan)Aug 3 | 7,000 shat $221.51 · $1.6M |
| Gloeckler MarkusChief Technology Officer | Sold (plan)Aug 3 | 3,425 shat $218.95 · $750K |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy